NDC 55154-3563-00 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-3563
- Requested NDC
- 55154-3563-00
- Package NDCs from labels
- 55154-3563-0, 55154-3563-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-3563-0 | Levothyroxine Sodium | 10 in 1 BAG | TABLET | 10 | 8 | |
| 55154-3563-0 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-3563 | LEVOTHYROXINE SODIUM TABLET [CARDINAL HEALTH 107, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240906_31a31756-68aa-4e01-bbb1-9d181f8d9181.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2026-10-16 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries, Inc. | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2026-10-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2026-10-14 | Warnings | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 5da80d6d-4895-ad6c-e063-6394a90ae6f5 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 5da82b4e-bf84-c482-e063-6394a90addf9 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 8bc641d8-0185-49b2-9c1f-d886bf5ce098 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966221 9J765S329G |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | 5d6d297d-770b-dd9f-e063-6294a90a4bb8 | 2026-10-02 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 1a2124e6-aea2-40dd-bb8d-52c58405a67e | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966222 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 48a366d8-f5ac-47b0-84e3-f88251def70c | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Omeprazole/Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Westminster Pharmaceuticals, LLC | d69c2f0f-4e8b-422a-8aaf-a825998b04e0 | 2026-09-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Major Pharmaceuticals | ebf340c9-0b6d-13d2-e053-2995a90ae338 | 2026-09-24 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | 28cdf049-acdb-4098-a5ca-e86257c81954 | 2026-09-24 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 224fe1a6-84e4-41eb-a328-1349f687f7f3 | 2026-09-22 | Warnings | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 01d2c8c9-db54-4002-8f79-4ec396531024 | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 255ad500-6656-4cd0-b4d1-10cc22f9e61b | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | cee5ca2e-4780-4c54-a895-0f9fb2986c1e | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.